ANT Desk

Anthropic PBC · Nasdaq Global Select · IPO terminal

Quote offline

Delayed quote

-

Loading a delayed ANT quote, if one is available. IPO price is $83.00.

Open-
High-
Low-
Volume-
Bid / Ask-
IPO price$83.00

Deal at a glance

Priced at $83, ticker ANT

Anthropic, PBC priced its Class A IPO on Nov 18, 2026. Shares were expected to begin trading on the Nasdaq Global Select Market on Nov 19 under the symbol ANT.

IPO proceeds$81.34B

980 million shares at $83.00. Upsized from 825 million and from a $70-$78 range. Company release, Nov 18; proceeds = 980M × $83.

Who sold956.4M / 23.6M

956,351,354 shares by Anthropic; 23,648,646 by selling stockholders. The company does not receive the selling-stockholder proceeds. Company release.

Reported value at $83~$1.08T / ~$1.5T

About $1.08 trillion on a shares-outstanding basis and about $1.5 trillion fully diluted, as reported by Axios, Nov 18. See the calculator for the share-count basis.

Alongside the IPO$26B placement

A concurrent private placement of non-voting shares at the IPO price, from a group that press reports said included Nvidia, Google, Microsoft, AMD, Broadcom, Micron, and TSMC Partners. This is not IPO proceeds. CNBC, Nov 18.

Scenario calculator

What a share price would imply

Move the price to see implied company value on two share-count bases, versus the $83 IPO price and the May 2026 Series H valuation. These are mechanical illustrations, not forecasts or a recommendation.

Implied, outstanding Est.-

13.24 billion shares, estimated

Implied, fully diluted Est.-

18.17 billion shares, estimated

Vs IPO price-

Percentage change from $83.00

FD vs Series H-

Versus the $965B post-money valuation on May 28, 2026

FD / Oct. run-rate Est.-
Greenshoe if fully used+$12.20B
Company IPO proceeds$79.38B

Share counts are estimates, not a final cap table. They start from the share table in the Nov 10, 2026 amended S-1, as summarized in public explainers: about 13.087 billion shares outstanding after the then-planned 825 million-share offering and concurrent placement, and about 18.013 billion on that filing's "additional adjustments" total (a fully diluted stand-in, built at the $74 midpoint). This calculator adds the 155 million-share upsizing announced on Nov 18, giving about 13.242 billion outstanding and 18.168 billion fully diluted. Treasury-method option dilution moves with the share price, and the final prospectus may differ. Axios's reported $1.08 trillion / $1.5 trillion figures at $83 are close to the pre-upsizing math. October run-rate revenue of about $81 billion is an operating metric defined in the company's materials, not GAAP revenue and not a forecast. The greenshoe is a 30-day option on up to 147 million additional shares (about $12.20 billion at $83) and had not been reported as exercised as of this build.

From the prospectus

Financial snapshot

Figures below come from press reports of Anthropic's IPO prospectus and from the company's IPO fact sheet. They are historical or operating metrics, not guidance.

ItemFigureSource
Revenue, nine months ended Sep 30, 2026$33.24BCNBC, Nov 18, citing the prospectus. About 1,200% above the same period a year earlier.
Revenue, third quarter of 2026$17.0BCompany IPO fact sheet.
Revenue, first half of 2026$16.3BAmended S-1, as summarized in contemporaneous filing explainers.
Revenue, full year 2025 / 2024$4.6B / $0.39BSame filing coverage of the S-1.
Run-rate revenue, Oct 31, 2026~$81BCompany fact sheet and CNBC. An operating metric (trailing 28-day usage fees × 13, plus monthly subscriptions × 12), not a substitute for reported revenue. CNBC said it was up about $10B from the prior month.
Operating loss, first nine months of 2026$1.3BAmended S-1, as summarized in filing explainers.
Net loss, first nine months of 2026$104BCNBC, Nov 19. It said about $94.3B of that came from changes in the fair value of convertible notes, derivatives, and SAFEs. The year-earlier period's net loss was $25.1B.

Also reported

Structure and context

ItemWhat is known
ListingNasdaq Global Select, symbol ANT. Offering expected to close Nov 20, 2026, subject to customary conditions. Underwriters include Goldman Sachs and Morgan Stanley. Company release, Nov 18.
Corporate formDelaware public benefit corporation. The S-1 describes a Long-Term Benefit Trust and special share classes, including Class F founder voting stock and Class T trust stock. See the prospectus for the actual governance terms.
Greenshoe30-day option for underwriters to buy up to 147 million additional Class A shares. Company release. Not counted as raised unless it is exercised.
Demand ReportedPress reports said the book was about six times oversubscribed. That is a demand claim, not an official proceeding size. Al Jazeera, Nov 19.
Retail allocation ReportedCoverage before pricing said Anthropic wanted a larger-than-usual retail slice, around 20% of the deal versus a more typical 5% to 10%. Treat this as reported intent, not a confirmed final allocation. MarketWatch / Morningstar.
Strategic holders ReportedTechCrunch, citing people familiar, said Amazon owned nearly 15% and Google almost 14% around the IPO. TechCrunch, Nov 18.
Co-founder sales ReportedCNBC, citing the prospectus, said each of the seven co-founders was selling 3.38 million shares, about $1.96 billion in total at $83. CNBC, Nov 18.
Employee wealth ScenarioCNBC reported that, at a $1.5 trillion valuation, about 4,250 of roughly 5,300 employees could be millionaires, with about 1,200 above $10 million, excluding the seven co-founders. This is a scenario, not a confirmed payout. CNBC, Nov 19.

2026 path

Road to the listing

Jun 1, 2026

Confidential IPO filing

Anthropic said it had confidentially filed for a U.S. IPO. Reuters, Jun 1.

Oct 26, 2026

S-1 made public

The registration statement was publicly filed. Press reports put the date at Oct 26. Al Jazeera, Nov 19.

Nov 10, 2026

Range set at $70 to $78

An amended filing set an expected range of $70 to $78, with 825 million shares then planned. CNBC, Nov 18.

Nov 18, 2026

Priced at $83, upsized to 980 million shares

6.4% above the top of the range. Registration declared effective the same day. Company release.

Nov 19, 2026

First day of trading, 9:30 a.m. ET

Shares were expected to begin trading on Nasdaq under ANT. Company release.

Nov 20, 2026

Offering expected to close

Subject to customary closing conditions. This is the expected settlement date, not a prediction about the second trading session. Company release.

Private rounds

Funding timeline

Official company announcements are marked as such. Where Anthropic did not publish a valuation, that field is left blank or labeled as reported.

DateRoundRaisedPost-money
May 28, 2021Series A Official$124MNot disclosed
Apr 29, 2022Series B Official$580MNot disclosed
May 23, 2023Series C Official$450MReported about $4.1B-$4.5B; not in the company post
Jan 2024Series D Reported$750MAbout $18.4B, per later databases and Forbes, Jan 11, 2024. No matching Anthropic press release was found.
Mar 3, 2025Series E Official$3.5B$61.5B
Sep 2, 2025Series F Official$13B$183B
Feb 12, 2026Series G Official$30B$380B
May 28, 2026Series H Official$65B$965B
Nov 18, 2026IPO pricing Official$81.34BAbout $1.08T / $1.5T, as reported; see calculator

Scale check

Largest IPOs by initial proceeds

Initial deal size only, not including any underwriter overallotment (greenshoe), from Renaissance Capital's all-time global IPO list. Amounts are nominal and unadjusted for inflation.

SpaceX's initial IPO was $75.0 billion on Jun 11, 2026. After underwriters fully exercised the greenshoe, total proceeds were about $85.7 billion, per CNBC, Jun 15, 2026. Anthropic's own greenshoe (up to 147 million shares, about $12.20 billion at $83) is still only an option. A separate $26 billion concurrent private placement sits alongside Anthropic's IPO and is not included in the $81.34 billion bar above.

Sourced coverage

Headlines with dates

These are real articles, not a simulated ticker feed. Timestamps are publication dates, not invented intraday clocks.